Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lonafarnib and Ritonavir for Chronic Hepatitis D
NCT02511431Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Jul 2015
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lonafarnib in hepatitis D (HDV), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Jul 2015; status: completed.
02
Drugs
lonafarnib
03
Conditions
hepatitis D (HDV)
Beyond the preview
Go deeper on NCT02511431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02511431.